TE
Tema ETFs Portfolio holdings
AUM
$377M
This Quarter Return
+13.47%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$377M
AUM Growth
+$41.9M
(+13%)
Cap. Flow
+$8.19M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
20.9%
Holding
176
New
29
Increased
67
Reduced
61
Closed
11
Top Buys
| 1 |
Eaton
ETN
|
$10M |
| 2 |
Cognex
CGNX
|
$7.72M |
| 3 |
CRH
CRH
|
$5.63M |
| 4 |
Linde
LIN
|
$5.21M |
| 5 |
Johnson Controls International
JCI
|
$3.81M |
Top Sells
| 1 |
Vulcan Materials
VMC
|
$5.25M |
| 2 |
APi Group
APG
|
$4.9M |
| 3 |
Rockwell Automation
ROK
|
$4.88M |
| 4 |
Clean Harbors
CLH
|
$4.34M |
| 5 |
Applied Industrial Technologies
AIT
|
$3.95M |
Sector Composition
| 1 | Industrials | 38.16% |
| 2 | Healthcare | 30.66% |
| 3 | Technology | 10.25% |
| 4 | Utilities | 8.88% |
| 5 | Materials | 5.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Edwards Lifesciences
EW
$47.7B
| $1.13M | 0.3% |
14,421
-2,122
| -13% | -$166K |
|
102
Advanced Energy
AEIS
$5.61B
| $1.12M | 0.3% |
+8,453
| New | +$1.12M |
|
103
ON Semiconductor
ON
$19.6B
| $1.11M | 0.3% |
+21,258
| New | +$1.11M |
|
104
Ionis Pharmaceuticals
IONS
$9.5B
| $1.11M | 0.3% |
28,161
+3,020
| +12% | +$119K |
|
105
Immunome
IMNM
$851M
| $1.07M | 0.29% |
+115,431
| New | +$1.07M |
|
106
Waters Corp
WAT
$17.6B
| $1.06M | 0.28% |
3,024
+208
| +7% | +$72.6K |
|
107
Danaher
DHR
$141B
| $1.03M | 0.27% |
5,221
-743
| -12% | -$147K |
|
108
Idexx Laboratories
IDXX
$51.2B
| $1.03M | 0.27% |
1,918
+137
| +8% | +$73.5K |
|
109
Elevance Health
ELV
$69.6B
| $1.02M | 0.27% |
+2,631
| New | +$1.02M |
|
110
McKesson
MCK
$86.2B
| $1.02M | 0.27% |
1,392
-182
| -12% | -$133K |
|
111
Martin Marietta Materials
MLM
$36.9B
| $998K | 0.27% |
+1,818
| New | +$998K |
|
112
DexCom
DXCM
$31.4B
| $995K | 0.26% |
11,401
-3,870
| -25% | -$338K |
|
113
Nurix Therapeutics
NRIX
$691M
| $924K | 0.25% |
81,112
+21,966
| +37% | +$250K |
|
114
Cogent Biosciences
COGT
$1.8B
| $845K | 0.22% |
117,639
+46,076
| +64% | +$331K |
|
115
Church & Dwight Co
CHD
$23B
| $815K | 0.22% |
+8,481
| New | +$815K |
|
116
Syndax Pharmaceuticals
SNDX
$1.37B
| $808K | 0.21% |
86,301
+65,132
| +308% | +$610K |
|
117
Day One Biopharmaceuticals
DAWN
$743M
| $808K | 0.21% |
124,310
+33,187
| +36% | +$216K |
|
118
Arista Networks
ANET
$177B
| $804K | 0.21% |
+7,862
| New | +$804K |
|
119
Cytokinetics
CYTK
$5.99B
| $793K | 0.21% |
23,996
-8,592
| -26% | -$284K |
|
120
Ascendis Pharma
ASND
$12.1B
| $704K | 0.19% |
4,078
-2,028
| -33% | -$350K |
|
121
Immunocore
IMCR
$1.78B
| $697K | 0.19% |
22,206
+6,778
| +44% | +$213K |
|
122
Masimo
MASI
$7.74B
| $664K | 0.18% |
3,949
-594
| -13% | -$99.9K |
|
123
Enliven Therapeutics
ELVN
$1.21B
| $654K | 0.17% |
32,579
+8,931
| +38% | +$179K |
|
124
Zymeworks
ZYME
$1.08B
| $651K | 0.17% |
51,855
+18,854
| +57% | +$237K |
|
125
HUTCHMED
HCM
$2.54B
| $641K | 0.17% |
+42,565
| New | +$641K |
|